BioVie, Inc. (BIVI)
1.31
-0.07
(-5.07%)
USD |
NASDAQ |
May 15, 16:00
1.32
+0.01
(+0.76%)
After-Hours: 20:00
BioVie EPS Diluted (Quarterly) : -0.6986 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lantern Pharma, Inc. | -0.362 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.270M |
| Total Expenses (Quarterly) | 5.270M |
| Enterprise Value | -2.925M |
| Earnings Yield | -326.1% |
| Normalized Earnings Yield | -326.08 |